ACR2021 - Day5a
Rheumnow Podcast - Een podcast door Dr. Cush

Tofacitinib and Malignancy Risk: Dr. Seoyoung KimPotpourri of Biosimilar Trials: Dr. Jonathan KayClosing a Chapter: Interview with the 84th ACR President 2020-2021, Kathryn Dao
Rheumnow Podcast - Een podcast door Dr. Cush
Tofacitinib and Malignancy Risk: Dr. Seoyoung KimPotpourri of Biosimilar Trials: Dr. Jonathan KayClosing a Chapter: Interview with the 84th ACR President 2020-2021, Kathryn Dao